DoD AI contracts fell from $138 million to $9.4 million — a 93% collapse. Meanwhile, Palantir's market cap surged past $350 billion, Anduril targeted a $60 billion valuation, and OpenAI closed the largest private fundraise in tech history at $852 billion. On one side, a cliff in the government's ledger. On the other, a frenzy in the capital markets.
To untangle this contradiction, Bear's Lens did something tedious: verified every claim.
Where the "93% Collapse" Comes From
Search "artificial intelligence" on the federal spending transparency platform, filter by DoD contracts, and the system reports a 75% decline in AI contract obligations. The DoD column is worse — down 93%. But over the same period, federal AI grants surged from $380 million to $1.28 billion, up 236%.
Contracts collapsed. Grants exploded. Two opposing curves that add up to a pleasant headline: federal AI spending doubles.
Bear's Lens ran contracts and grants separately and found an anomaly — AI grants up 236%, while machine learning grants fell 55%. That divergence suggests the grant-side growth wasn't real AI investment. Some non-AI program happened to mention "artificial intelligence" in its description and got swept up by keyword search.
The $10 Billion Misunderstanding
That program is the Rural Health Transformation Program. The One Big Beautiful Bill Act, signed in July 2025, created a rural healthcare overhaul covering all 50 states — $50 billion over five years, $10 billion annually, administered by CMS, disbursed to state health departments.
Every recipient was a state-level government agency: Texas $281 million, Alaska $272 million, California $234 million. Project summaries list telehealth infrastructure, EHR interoperability, chronic disease monitoring. AI appears on the line reading "appropriate use of artificial intelligence" — after telehealth, cybersecurity, and data sharing.
To secure federal funding, states repackaged routine health-IT projects as "AI innovation." EHR analytics became "predictive AI." Remote consultations became "AI-assisted diagnosis." When the spending platform's search engine picked up these descriptions, a single $200 million state healthcare allocation could be counted as federal AI spending, drowning out dozens of genuine AI research grants.
"Federal AI spending doubled" is not technically a lie. But it describes a $10 billion rural healthcare fund that happened to mention AI — not an expansion of defense AI capability. The recipient list contains no Palantir, no Anduril, no OpenAI, no Scale AI.
The Missing Billions
Data lag explains only part of the picture. Even using only October–December 2025 — a fully matured data window — DoD AI contracts still fell from $53.3 million to $9.4 million, an 82% decline.
The deeper question: what share of real defense AI spending does the public platform actually capture? Almost nothing. The Pentagon's FY2026 budget created a standalone "autonomy and autonomous systems" line item totaling $13.4 billion. The keyword search returned just $9.4 million — a tiny fragment.
Bear's Lens cross-verified on the federal procurement disclosure platform, searching for Maven, Replicator, Linchpin, Palantir, Anduril, and Scale AI. Zero results across the board. Palantir's reported multi-billion-dollar Maven contract, Anduril's reported $20 billion Army contract, CDAO's $200 million prototype contracts with OpenAI and Google — all invisible on both federal transparency systems.
The reason is a structural shift in procurement instruments. The DoD is systematically moving AI procurement from traditional FAR contracts — which are fully recorded on public platforms — to Other Transaction Authority (OTA). OTAs have minimal reporting requirements. The GAO has repeatedly flagged severe incompleteness: one audit found over $40 billion in OTAs unreported; another testimony identified $77.5 billion in OTA records absent from the spending platform.
The Battlefield's Answer
On February 28, 2026, the U.S. military launched Operation Epic Fury in Iran — the largest Middle East operation since 2003. According to military statements, Palantir's Maven Smart System played a central role from the outset, reportedly generating over a thousand strike options on the first day. In the first 10 days, U.S. forces struck approximately 5,000 targets at a scale and speed surpassing any previous Middle East operation.
AI is no longer the Pentagon's experiment. It is infrastructure in large-scale combat. The Pentagon isn't cutting AI procurement — it's moving it off the public ledger into the dark, while deploying it on the battlefield at unprecedented scale.
Who's Paying
Palantir's market cap sits at roughly $350 billion on annual revenue of $4–4.5 billion — a revenue multiple in the tens, far exceeding Lockheed Martin ($115 billion market cap, $71 billion revenue, 1.6x multiple). From September 2025 to March 2026, total federal AI contract obligations per quarter fell from $183 million to $14.7 million. Palantir's stock dropped 20%, while Nvidia — with government revenue under 5% — fell only 7%.
What props up these valuations isn't current federal payment obligations. It's expectations: contract fulfillment over the next decade, market monopoly, sovereign dependency. In 2025, defense tech VC deals totaled $49.1 billion with exits at $54.4 billion — both all-time records. Those paying for the "defense AI premium" are not the Pentagon's budget. They are the global capital markets.
Three Cracks
The demand is real. The monopoly is real. The battlefield validation is real. But pricing at dozens of times revenue bets on a perfect future — and at least three cracks threaten that bet.
Concentration. Palantir's multi-billion-dollar Army agreement needs a decade to materialize. Maven grew from under $500 million to a program targeting over $10 billion. When a single supplier locks in military-wide infrastructure, any political shift, technical failure, or audit issue could trigger systemic shock. Palantir has a long history of heavy insider selling.
Political fragility. The Anthropic supply-chain-risk designation proves that one administrative decision can overnight upend an AI supplier's entire government business. DOGE-driven reviews are creating procurement disruptions. Congressional scrutiny of AI weapons keeps intensifying. The ethics threshold has become a commercial moat — clearing the strongest cross-sector competitors, granting the remaining defense-native firms unprecedented pricing power.
Ecosystem erosion. The most hidden and most dangerous crack. Even as defense AI procurement expands, civilian research funding sustaining the long-term innovation pipeline is being systematically drained. NSF faces steep cuts, DOE spending has dropped sharply, NASA is contracting. The breakthrough technologies defense AI firms will need by 2030 — next-generation algorithms, new computing paradigms, foundational math and physics — are precisely what today's slashed research budgets were supporting.
Is the defense AI valuation premium built on a premise already disproved by data? No. The "93% contract collapse" is a statistical artifact of keyword search methodology. Real demand is accelerating through a $13.4 billion autonomous systems budget line and battlefield deployment — it has simply moved to places public data systems cannot see.
But the current pricing is no longer paying for those truths. It's paying for an assumption: that contracts will materialize smoothly, the political environment will stay stable, the competitive landscape will remain frozen, and the innovation pipeline won't break. Every dataset Bear's Lens examined says the same thing — each of those assumptions is more fragile than the market has priced in.
The ones paying for the "defense AI premium" are not the Pentagon. They are investors in the global secondary market, paying dozens of times revenue for a ticket to a perfect future. Whether that ship reaches its destination is not a question about demand. It is a question about pricing.
No comments:
Post a Comment